http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MAX Power to Showcase Natural Hydrogen Leadership at 2026 Global Energy Show Canada
-
JONATHAN BAILEY STEPS INTO HIS NEW ROLE AS THE MARTINI MAN
-
Infrastructure Monitoring and Control Provider Acorn to Webcast Investor Presentation at Planet MicroCap Las Vegas Powered by MicroCapClub Conference Wed. June 17 at 12:30 PT
-
Victory Capital reports total client assets of $342.4 billion for may
-
Soluna reports May 2026 operations across data center projects
-
TG Therapeutics reports positive phase 1 data for BRIUMVI in myasthenia gravis
-
Soluna Announces Monthly Business Update
-
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
-
Victory Capital Reports May 2026 Total Client Assets
-
AST SpaceMobile schedules BlueBird satellites 8-10 launch for june 17
-
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
-
TRU Precious Metals' 2026 Field Works Program Gets Underway at Golden Rose
-
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
-
Thermal Energy International to Present at Planet MicroCap Las Vegas
-
BioSapien Wins 2026 Startup World Cup Silicon Valley Regional Competition
-
With SOL Outpacing Every Major Blockchain in Q1 2026, Solana Unchained Moves to Capture the Next Wave of Ecosystem Growth
-
AST SpaceMobile Announces Launch Date for BlueBird Satellites 8, 9, and 10
-
West Point Gold Intersects 19.7m of 9.06 g/t Au and 35.7m of 3.2 g/t Au, Improving Confidence at NE Tyro
-
Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting on June 30, 2026
-
Personalis gets CE-IVD marking for blood collection kits in Europe
-
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
-
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
-
Interactive Brokers offers commission-free BlackRock ETFs in Europe
-
Interactive Brokers Launches Commission-Free iShares ETFs from BlackRock through Recurring Investment Feature Across Europe
-
Zai Lab wins China approval for cervical cancer drug TIVDAK
-
Guggenheim Securities Hires Ross Board to Expand Energy, Power & Energy Transition Investment Banking in Europe
-
Guggenheim Securities Hires Ross Board to Expand Energy, Power & Energy Transition Investment Banking in Europe
-
Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
-
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
-
Little Pepe Surpasses $28.1 Million in Presale Funding as Project Advances Layer-2 Ecosystem Development
-
Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer
-
BratGen.io Capitalizes on the Brat Economy: How a Free Online Tool Turned a Music Aesthetic Into a Content Creation Movement
-
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
-
U.S. Virgin Islands Showcases Regional Leadership, Expanding Connectivity, and Continued Growth in the Tourism Sector at Caribbean Week in New York City
-
Gilead and Merck announce successful HIV treatment trial results
-
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
-
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
-
Merck and Gilead discontinue lung cancer drug combination trial
-
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
-
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
-
CSX Unveils Commemorative Locomotives Marking America’s 250th Anniversary
-
HII partner launches manufacturing line for ROMULUS unmanned vessels
-
Michael J. Fox Foundation Recognized for Excellence in Video Storytelling with Multiple Telly Awards
-
HII Partner Bayou Metals Launches Dedicated Manufacturing Line to Accelerate ROMULUS USV Production
-
SOUR PATCH KIDS® BESTIES: A Candy Meant to Be Shared
-
Energy Tech Solution (ETS) installs prismatic battery assembly line at Pacific Northwest National Laboratory
-
BeyondTrust Selected for Anthropic's Project Glasswing to Help Secure Critical Digital Infrastructure
-
BeyondTrust Selected for Anthropic's Project Glasswing to Help Secure Critical Digital Infrastructure
-
Pega Honors Partners at PegaWorld 2026 for Driving AI‑Powered Enterprise Transformation
-
Bojangles Brings the Heat Back to Breakfast With Return of Breakfast Bo-Rito and Debut of New Fuego Breakfast Bo-Rito
